The 18th JBSA Annual Conference Program
November 14-15, 2018
Toyama Sunrise, Shinjuku-ku, Tokyo

November 14, 2018 (1st Day)
Reception: 9:30～
Opening remark〔9：55～10：00〕
Chairman: Shigeru Morikawa (National Institute of Infectious Diseases)
Extension symposium〔10：00～11：00〕
Vaccine development for highly pathogenic agents
Chairman: Masayuki Saijo (National Institute of Infectious Diseases)
1) International status of the countermeasures’ development for the risk of bioterrorism,
in which variola virus would be used as a bioweapon
Department of Virology 1, National Institute of Infectious Diseases
Masayuki Saijo
2) Development of Ebola vaccine based on a highly attenuated smallpox vaccine strain,LC16m8
Department of Virology I, National Institute of Infectious Diseases
Tomoki Yoshikawa
3) Development of recombinant vaccines against emerging and re-emerging
infectious diseases using replication-incompetent rabies virus vector．
Department of Virology I, National Institute of Infectious Diseases
Mutsuyo Takayama-Ito4) Establishment of animal models for highly pathogenic infectious diseases
Department of Pathology, National Institute of Infectious Diseases
Noriyo Nagata
Workshop〔11：10～12：40〕
Laboratory animal biosafety
Chairman: Ken-Ichi Hanaki (National Institute of Infectious Diseases)
1) Lessons learned from appearance of hemorrhagic fever with renal syndrome (HFRS)
incidence in laboratory animal facilities

Hokkaido University Graduate School of Medicine
Jiro Arikawa
2) Alert: LCMV infection detected
RIKEN BioResource Research Center
Fumio Ike
3) Decontamination Rack for Infection Experiments
TECNIPLAST JAPAN CO., LTD.
Yuji Omura
General Meeting〔13：40～14：10〕
Symposium 1〔14：20～15：50〕
Ebola hemorrhagic fever in Democratic Republic of Congo
Chairman: Shuetu Fukushi (National Institute of Infectious Diseases)
1) Overview of the Japan Disaster Relief (JDR) Infectious Diseases Response TeamInternational Cooperation Bureau, Ministry of Foreign Affairs of Japan
Tomonori Hasegawa
2) The public health and epidemiological activities of Japan Disaster Relief Infectious
Disease Response Team for Ebola outbreak response in Equateur province,
Democratic Republic of Congo
Bureau of International Health Cooperation, National Center for Global Healthand Medicine
Masataro Norizuki
3) Laboratory diagnosis and biosafety at the National Institute of Biomedical Research(INRB), Democratic Republic of Congo
Department of Virology I, National Institute of Infectious DiseasesMasayuki Shimojima
Educational lecture1〔16：10～17：10〕
Chairman: Kiyoshi Tanabayashi (National Institute of Infectious Diseases)
Evaluation of Japan’s Health Security Capacity by WHO Joint External Evaluation(JEE) and Biosafety & Biosecurity
Department of Health Crisis Management, National Institute of Public HealthTomoya Saito

November 15, 2018 (2nd Day)
Reception: 9:30～
Applied Subjects 1〔10：00～11：00〕
Chairman: Shigeru Morikawa (National Institute of Infectious Diseases)
1) Present status on personal protection against biological hazardous agents
Division of Biosafety Control and Research, National Institute of Infectious
DiseasesKatsuaki Shinohara, et al.
2) Consideration for control of inter-room airflow in containment facilities and its
evaluation method
Division of Biosafety Control and Research, National Institute of Infectious
Diseases
Toshihiko Harada, et al.
3) Comprehensive analyses on stability and inactivation of Francisella tularensis
Department of Veterinary Science, National Institute of Infectious Diseases
Akihiko Uda, et al.
4) Inactivation of severe fever with thrombocytopenia syndrome virus for laboratory
safetyDepartment of Virology 1, National Institute of Infectious Diseases
Shuetsu Fukushi, et al.
Applied Subjects 2〔11：20～12：00〕
Chairman: Kazuyoshi Sugiyama (National Institute of Infectious Diseases)
5) Materials placement of the work surface of BSC
Hitachi Industrial Equipment Systems Co.,Ltd.
Keiichi Ono
6) Consideration of the best sterilization condition for cynomolguses by using of
pre-vacuum autoclave.
Division of Biosafety Control and Research, National Institute of Infectious
Diseases
Shigeo Iki
7) Information and Risk management of Specialized Experiment Facility in Exotic
Disease Research Station of National Institute of Animal Health, National
Agriculture and Research Organization
Biorisk Manager for Exotic Diseases, National Institute of Animal Health, NationalAgriculture and Research Organization
Tomoaki Shimazaki
Symposium 2〔13：00～14：30〕
Crisis management for infection and biosafety in medical care
Chairman: Hiroyuki Kunishima (St. Marianna university), Eiichi Kodama (Tohokuuniversity)
1) Biosafety in health care for the Tokyo 2020 Olympic and Paralympic Games
Department of Infectious Diseases. St. marianna university
Hiroyuki Kunishima2) Biosafety in medical institutions in Asia
JICA Project for Improvement of Hospital Management Competency (at Cho Ray
Hospital in HCMC) Expert ／ National Center for Global Health and Medicine
Bureau of International Health Cooperation
Hitomi Kurosu
3) Biosafety in Disaster Medicine
International Research Institute of Disaster Science, Tohoku university
Eiichi Kodama
Educational lecture2〔16：40～15：40〕
Chairman: Takeshi Kurata (International University of Health and Welfare)
About the consideration situation toward establishment of BSL-4 facilities inNagasaki University
National Research Center for the Control and Prevention of Infectious Diseases,
Nagasaki University
Kensuke Nakajima